Metronom Continuous Glucose Monitoring System

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabete Mellitus
Interventions
OTHER

Metronom CGM device

Patient receives three Metronom CGM devices on day 1. On day 1, 4, 7 and 14, a hypo- or hyperglycaemic experiment will start according to allocation by randomizer.

OTHER

Metronom CGM device

Patient receives three Metronom CGM devices on day 1. On day 1, 7, 10 and 14, a hypo- or hyperglycaemic experiment will start according to allocation by randomizer.

Trial Locations (2)

Unknown

Medical University of Graz, Graz

Steno diabetes center, Copenhagen

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Medical University of Graz

OTHER

lead

Metronom Health

INDUSTRY